Blanquer, Elvie C.

HRN: 24-97-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2024
CEFUROXIME 1.5GM (VIAL)
05/06/2024
05/12/2024
IV
500mg
BID
NSVD MRLE Wbc 19.4

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines